A new cancer vaccine may keep melanoma from coming back
The personalized mRNA shot teaches the body to attack a patient’s specific melanoma cells
A cancer vaccine candidate shows promise in clinical trials, according to pharmaceutical companies Moderna and Merck. The shot aims to teach a patient’s body to attack melanoma cancer cells in combination with the immunotherapy drug.
FRED TANNEAU/AFP/Getty Images